New retrospective six-month post-implantation data on the efficacy of Boston Scientific’s Spectra spinal cord stimulation system for low-back pain will be presented at the World Institute of Pain (WIP) World Congress in Maastricht, The Netherlands, May 7-10, 2014.
Among the data presentations are the following:
- Highly Significant Clinical Outcomes with a 32-Contact multiple independent constant current (MICC) spinal cord stimulation system (WIP-0564)
- Highly Significant Reduction in Chronic Low Back Pain with a 32-Contact multiple independent constant current (MICC) spinal cord stimulation system (WIP-0565)
